Scholars Central

Conference abstractPublished 7 Oct 2013

Dual-imaging enable nanoparticles for diagnosis and therapy of prostate cancer

Authors: Kytai T. Nguyen

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

With an increasing rate of cancers, the need for effective cancer management has led to the development of theranostic systems for cancer diagnosis and therapy. Conventional techniques for cancer management, however, have limited success due to inaccurate diagnosis and systemic toxicity of therapeutic reagents. Using novel biodegradable photoluminescent polymers developed in our group and superparamagnetic nanoparticles (MNPs), we have developed prostate cancer cell-selective dual- imaging enabled nanoparticles to overcome a few limitations of conventional technologies. These nanoparticles were synthesized and characterized for their properties in vitro . The stable and well dispersed nanoparticles had an average diameter of about 200 nm and displayed strong superparamagnetic properties. Dual-imaging capabilities of these nanoparticles via optical imaging and magnetic resonance imaging (MRI) demonstrated that nanoparticles exhibited bright fluorescence under UV light and dark negative contrast in MRI. Moreover, cytocompatibility studies conducted with human dermal fibroblasts using MTS assays showed excellent cytocompatibility up to a concentration of 500μg/ml. Furthermore, cellular uptake studies using two different prostate cancer cells, PC3 and LNCaP, demonstrated a dose-dependent nanoparticle uptake. The presence of external magnetic field also reinforced the uptake of these nanoparticles by prostate cancer cells. In addition, these nanoparticles released the model drug, Doxorubicin, in a sustained manner up to 3 weeks. Our results suggest that these nanoparticles possess unique capabilities for prostate cancer cell-selective uptake, magnetic targeting, dual-imaging and controlled drug release, and could be used for prostate cancer diagnosis and therapy in the future.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Material Sciences & Engineering.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Material Sciences & Engineering
  • SubjectEngineering
  • SubjectMaterials Science
  • BylineArticles whose byline prints “Kytai T. Nguyen”